UPMC Enterprises acquired RxAnte to advance analytics, workflow and clinical interventions focused on reducing costs connected with underuse, overuse and misuse of prescription drugs.
Read more on Healthcare IT News here.
Healthcare IT News: UPMC invests in predictive analytics, population health company RxAnte
Related Resources
More Resources
10.08.18
Value in Medication Adherence: Where Costs and Quality Intersect for MAPD Plans
Blog Post
For Medicare Advantage plans, value-based care is a double-edged sword. It can make it easier to grasp the importance of members’ needs. But it can create heightened sensitivity to the pressures of quality measures. We find that it helps to take a step back when looking at costs and quality.
10.02.18
Health Plans & Cut Points – Getting Ahead
Blog Post
Each year, cut points are announced in the fall and Medicare Advantage Part D (MAPD) plans anxiously anticipate their impact on Star Ratings. We interviewed our vice president of client services, Kerri Petrin, to find out what tips, tricks, and advice she gives to health plans in times like these.
09.24.18
Analyzing vs. Predicting – MAPD Plans Need Both for Better Star Ratings
Blog Post
Although there is some value in using trends from previous years to inform strategy, it misses the mark when it comes to improving adherence rates. To help plans inform planning and drive improvement, we take a closer look at comparing retrospective vs. prospective strategies.